Showing results (311-320 of 2,812) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|April 25, 2018
Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 DiabetesSuresh Rama Chandran, Wei Lin Tay, Weng Kit Lye, et al.Diabetes Technology & Therapeutics|April 3, 2018
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)Arndís F Ólafsdóttir, William Polonsky, Jan Bolinder, et al.Diabetes Technology & Therapeutics|July 7, 2018
Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes MellitusMarc D Breton, Stephen D Patek, Dayu Lv, et al.Diabetes Technology & Therapeutics|August 20, 2016
Patient-Centered Care, Glycemic Control, Diabetes Self-Care, and Quality of Life in Adults with Type 2 DiabetesJoni S Williams, Rebekah J Walker, Brittany L Smalls, et al.Diabetes Technology & Therapeutics|May 2, 2017
Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose TargetPaolo Rossetti, Carmen Quirós, Vanessa Moscardó, et al.Diabetes Technology & Therapeutics|May 2, 2017
Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive ControlLauren M Huyett, Trang T Ly, Gregory P Forlenza, et al.Diabetes Technology & Therapeutics|May 3, 2017
Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 DiabetesAli Emami, Malgorzata E Willinska, Hood Thabit, et al.Diabetes Technology & Therapeutics|May 26, 2017
Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 DiabetesDavid Slattery, Pratik ChoudharyDiabetes Technology & Therapeutics|May 26, 2017
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?Ramzi A AjjanDiabetes Technology & Therapeutics|August 24, 2016
3 Screen ELISA for High-Throughput Detection of Beta Cell Autoantibodies in Capillary BloodAnette-G Ziegler, Florian Haupt, Marlon Scholz, et al.Pageof 282